Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / FLGT - Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology

FLGT - Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology

May, 02 2025 12:28 PM Fulgent Genetics Inc.

2025-05-02 12:28:11 ET

More on Fulgent Genetics

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript
Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy
Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript
Fulgent Genetics rises on earnings, revenue beat
Fulgent Genetics beats top-line and bottom-line estimates; reaffirms FY25 outlook

For further details see:

Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology

Stock Information

Company Name:	Fulgent Genetics Inc.
Stock Symbol:	FLGT
Market:	NASDAQ
Website:	fulgentgenetics.com

FLGT FLGT Quote FLGT Short FLGT News FLGT Articles FLGT Message Board

Get FLGT Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.